NeoGenomics, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
NeoGenomics, Inc. (NEO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $8.98 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-07-28
- NeoGenomics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $9.09, a 12.22% increase year-over-year.
- NeoGenomics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $8.10, a 1.63% increase year-over-year.
- NeoGenomics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $7.97, a 20.38% decline year-over-year.
- NeoGenomics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $10.01, a 26.93% decline year-over-year.
- NeoGenomics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $8.63, a 1.93% decline from fiscal 2024.
- NeoGenomics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $8.80, a 18.44% decline from fiscal 2023.
- NeoGenomics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $10.79, a 0.74% decline from fiscal 2022.
- NeoGenomics, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $10.87, a 9.03% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.98 10-Q · filed 2026-07-28 | |||
| 2026-03-31 | $9.09 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | $8.63 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $8.10 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | $8.10 10-Q · filed 2025-07-29 | |||
| 2025-03-31 | $8.10 10-Q · filed 2025-04-29 | |||
| 2024-12-31 | $8.80 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $8.86 10-Q · filed 2024-11-05 | |||
| 2024-06-30 | $8.38 10-Q · filed 2024-07-30 | |||
| 2024-03-31 | $7.97 10-Q · filed 2024-04-30 | |||
| 2023-12-31 | $10.79 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $10.70 10-Q · filed 2023-11-06 | |||
| 2023-06-30 | $10.07 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $10.01 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $10.87 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $11.35 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $12.65 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $13.70 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | $9.97 10-K · filed 2024-02-20 | |||
| 2021-09-30 | $10.85 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | $10.89 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $8.60 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $7.96 10-K · filed 2023-02-24 | |||
| 2020-09-30 | $7.75 10-Q · filed 2020-10-29 | |||
| 2020-06-30 | $7.42 10-Q · filed 2020-07-31 | |||
| 2020-03-31 | $7.58 10-Q · filed 2020-04-29 | |||
| 2019-12-31 | $6.83 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $6.58 10-Q · filed 2019-11-13 | |||
| 2019-06-30 | $6.26 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | $6.23 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $5.48 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $5.60 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | $5.53 10-Q · filed 2018-08-06 | |||
| 2018-03-31 | $4.14 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $3.84 10-K · filed 2020-02-28 | |||
| 2017-09-30 | $3.73 10-Q · filed 2017-11-13 | |||
| 2017-06-30 | $3.14 10-Q · filed 2017-08-07 | |||
| 2017-03-31 | $2.23 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $1.69 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $1.61 10-Q · filed 2016-11-07 | |||
| 2016-06-30 | $0.92 10-Q · filed 2016-08-05 | |||
| 2016-03-31 | $0.92 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | $1.45 10-K · filed 2018-03-13 | |||
| 2015-09-30 | $1.61 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $1.54 10-Q · filed 2015-07-31 | |||
| 2015-03-31 | $1.48 10-Q · filed 2015-05-11 | |||
| 2014-12-31 | $0.76 10-K · filed 2017-03-14 | |||
| 2013-12-31 | $0.85 10-K · filed 2016-04-18 | |||
| 2012-12-31 | $1.02 10-K · filed 2015-03-03 | |||
| 2011-12-31 | $0.95 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |